Company attributes
Industry
B2X
Founder
Legal Name
Excision BioTherapeutics Inc.
Number of Employees (Ranges)
11 – 50
Email Address
info@mysite.com
inquiries@excisionbio.com
Full Address
988 Market Street San Francisco, CA 94102 United States
CIK Number
Place of Incorporation
Investors
DUNS Number
080367587
Founded Date
January 1, 2015
Total Funding Amount (USD)
70,750,000
Latest Funding Round Date
February 17, 2021
Latest Funding Type
Technologies Used
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
60,000,000
Excision BioTherapeutics is a company that develops CRISPR-based therapies against viral diseases. It develops and manufactures gene-editing therapeutics that fight against the viral genes in humans. Excision BioTherapeutics was founded by Thomas Malcolm.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
